Ironwood Financial’s Asensus Surgical, Inc. ASXC Stock Holding History

Ironwood Financial’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40	Closed	–	–	577
2021 Q3	$0	Hold	40	–	–	﹤0.01%	609
2021 Q2	$0	Hold	40	–	–	﹤0.01%	595
2021 Q1	$0	Buy	+40	New	+$145	﹤0.01%	579

Other funds holding ASXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Ironwood Financial's ASXC Position: Q4 2021 in Review

Ironwood Financial sold out of Asensus Surgical, Inc. (ASXC) in Q4 2021, closing a stake of 40 shares.

Ironwood Financial first reported a position in ASXC in Q1 2021 and held it in 3 quarters. The position peaked at $0 in Q3 2021. 114 funds tracked by Wall St. Rank hold ASXC as of Q4 2021.

Ironwood Financial reported no remaining Asensus Surgical, Inc. position as of Q4 2021 after selling out during the quarter.
Ironwood Financial sold 40 Asensus Surgical, Inc. shares in Q4 2021.
Ironwood Financial first reported a position in Asensus Surgical, Inc. in Q1 2021 and held it in 3 quarters.
Ironwood Financial's Asensus Surgical, Inc. position peaked at $0 in Q3 2021.
114 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.